Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veracyte (VCYT) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to $42.0 million.

  • Veracyte's Free Cash Flow rose 5138.34% to $42.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.2 million, marking a year-over-year increase of 7388.15%. This contributed to the annual value of $63.8 million for FY2024, which is 8624.38% up from last year.
  • Veracyte's Free Cash Flow amounted to $42.0 million in Q3 2025, which was up 5138.34% from $32.3 million recorded in Q2 2025.
  • Veracyte's Free Cash Flow's 5-year high stood at $42.0 million during Q3 2025, with a 5-year trough of -$41.8 million in Q1 2021.
  • For the 5-year period, Veracyte's Free Cash Flow averaged around $7.3 million, with its median value being $7.6 million (2021).
  • As far as peak fluctuations go, Veracyte's Free Cash Flow crashed by 89805.56% in 2022, and later skyrocketed by 57452.14% in 2023.
  • Veracyte's Free Cash Flow (Quarter) stood at $7.6 million in 2021, then grew by 3.51% to $7.9 million in 2022, then soared by 65.84% to $13.1 million in 2023, then skyrocketed by 56.13% to $20.4 million in 2024, then surged by 105.88% to $42.0 million in 2025.
  • Its Free Cash Flow was $42.0 million in Q3 2025, compared to $32.3 million in Q2 2025 and $3.5 million in Q1 2025.